HSBC analyst Rajesh Kumar hit Regeneron Pharmaceuticals and Zoetis with sharp target price cuts on Monday, flagging growing pressure across the healthcare space.
Regeneron's target dropped to $880 from $990. Zoetis took the bigger hit — its target fell 32% from $140 to just $95. Both remain rated Buy, but the cuts signal a meaningful downgrade in conviction. Zoetis has a $31.4B market cap. Short sellers show little alarm yet, with SI at 4.1% of free float.
In a contrasting move, HSBC analyst Sidharth Sahoo raised his target on UnitedHealth Group to $380 from $300. The managed care giant carries a $386B market cap. The upgrade comes as UNH has faced significant pressure in recent months following executive-level turmoil. Short interest sits at just 1.9% of free float.
Microsoft also drew attention after Wolfe Research's Alex Zukin cut his target to $525 from $570, dropping from Buy. The consensus average target now sits at $560. At a $2.9T market cap, even small target shifts move big money.
Skyworks Solutions bucked the trend. Its consensus target edged up to $73.69 — a rare positive signal for the chip supplier amid continued sector uncertainty.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
